Home › Funds › FIDEURAM - INTESA SANPAOLO PRIVATE BANKING S.P.A. › VRTX

FIDEURAM - INTESA SANPAOLO PRIVATE BANKING S.P.A. position in VRTX

VERTEX PHARMACEUTICALS INC · Health Care

FIDEURAM - INTESA SANPAOLO PRIVATE BANKING S.P.A. reported holding 40,454 shares of VRTX (VERTEX PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$21.1M, representing 0.60% of its reported portfolio and ranking #38 among its reported holdings. FIDEURAM - INTESA SANPAOLO PRIVATE BANKING S.P.A. has disclosed VRTX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)40.45K sh
Reported value held$21.15M
Portfolio Weight0.60%
First reportedQ4 2025
Last changeAdd
Updated2026-10-22

Last updated: 2026-10-22 · Source: SEC EDGAR Form 13F-HR

How FIDEURAM - INTESA SANPAOLO PRIVATE BANKING S.P.A.'s VRTX position evolved

FIDEURAM - INTESA SANPAOLO PRIVATE BANKING S.P.A. first disclosed a stake in VRTX in Q4 2025 at 31,281 shares (US$14.2M). The position peaked in Q3 2026 at 40,454 shares, worth US$21.1M. Across 4 filings, FIDEURAM - INTESA SANPAOLO PRIVATE BANKING S.P.A. increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 40,454 shares valued at US$21.1M — an increase of 1,702 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2025 31.28K $14.18M New
Q1 2026 34.99K $15.62M Add
Q2 2026 38.75K $19.25M Add
Q3 2026 40.45K $21.15M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VRTX and 13F data

VRTX (VERTEX PHARMACEUTICALS INC) is a Health Care company. 33 other funds we track also report a position in VRTX — the largest reported positions include Capital World Investors (US$12.97B), Capital World Investors (US$12.97B), Capital Research Global Investors (US$9.68B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VRTX

All VRTX fund holders →

FAQ

How long has FIDEURAM - INTESA SANPAOLO PRIVATE BANKING S.P.A. held VRTX?

FIDEURAM - INTESA SANPAOLO PRIVATE BANKING S.P.A. has disclosed VRTX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is FIDEURAM - INTESA SANPAOLO PRIVATE BANKING S.P.A.'s current position in VRTX?

As of Q3 2026, FIDEURAM - INTESA SANPAOLO PRIVATE BANKING S.P.A. holds 40.45K shares of VRTX (VERTEX PHARMACEUTICALS INC), valued at $21.15M, representing 0.60% of its reported portfolio and ranking #38.

Has FIDEURAM - INTESA SANPAOLO PRIVATE BANKING S.P.A. been buying or selling VRTX?

In the latest 13F filing (Q3 2026), FIDEURAM - INTESA SANPAOLO PRIVATE BANKING S.P.A. increased its position in VRTX. The position peaked in Q3 2026 at 40.45K shares.

Which other funds hold VRTX?

Other major institutional holders of VRTX include Capital World Investors, Capital World Investors, Capital Research Global Investors, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.